Involvement of glyceraldehyde-3-phosphate dehydrogenase in rotenone-induced cell apoptosis: Relevance to protein misfolding and aggregation

Brain Research

Volumn 1279, Issue , 2009, Pages 1-8

  Huang, Jinsha ^a   Hao, Lijun ^a   Xiong, Nian ^a   Cao, Xuebin ^a   Liang, Zhihou ^a   Sun, Shenggang ^a   Wang, Tao ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Glyceraldehyde 3 phosphate dehydrogenase; Lewy body; Parkinson's disease; Rotenone

Indexed keywords

DISULFIDE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); ROTENONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; DEGENERATIVE DISEASE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DISULFIDE BOND; LEWY BODY; MITOCHONDRION; NERVE CELL; NONHUMAN; PARKINSON DISEASE; PARKINSONISM; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN FOLDING; RAT;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; APOPTOSIS; CELL NUCLEUS; CYTOSOL; ENZYME ACTIVATION; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; MITOCHONDRIA; PC12 CELLS; PROTEIN FOLDING; PROTEIN MULTIMERIZATION; RATS; RNA, MESSENGER; ROTENONE; SOLUBILITY; TIME FACTORS; UNCOUPLING AGENTS;

EID: 67649410138     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2009.05.011     Document Type: Article

References (33)

1. Barbini L., Rodriguez J., Dominguez F., and Vega F. Glyceraldehyde-3-phosphate dehydrogenase exerts different biologic activities in apoptotic and proliferating hepatocytes according to its subcellular localization. Mol. Cell Biochem. 300 (2007) 19-28
2. Betarbet R., Sherer T.B., MacKenzie G., Garcia-Osuna M., Panov A.V., and Greenamyre J.T. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat. Neurosci. 3 (2000) 1301-1306
3. Buchczyk D.P., Briviba K., Hartl F.U., and Sies H. Responses to peroxynitrite in yeast: glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as a sensitive intracellular target for nitration and enhancement of chaperone expression and ubiquitination. Biol. Chem. 381 (2000) 121-126
4. Chuang D.M., Hough C., and Senatorov V.V. Glyceraldehyde-3-phosphate dehydrogenase, apoptosis, and neurodegenerative diseases. Annu. Rev. Pharmacol. Toxicol. 45 (2005) 269-290
5. Colell A., Ricci J.E., Tait S., Milasta S., Maurer U., Bouchier-Hayes L., Fitzgerald P., Guio-Carrion A., Waterhouse N.J., Li C.W., Mari B., Barbry P., Newmeyer D.D., Beere H.M., and Green D.R. GAPDH and autophagy preserve survival after apoptotic cytochrome c release in the absence of caspase activation. Cell 129 (2007) 983-997
6. Cumming R.C., and Schubert D. Amyloid-beta induces disulfide bonding and aggregation of GAPDH in Alzheimer's disease. FASEB J. 19 (2005) 2060-2062
7. Du Z.X., Wang H.Q., Zhang H.Y., and Gao D.X. Involvement of glyceraldehyde-3-phosphate dehydrogenase in tumor necrosis factor-related apoptosis-inducing ligand-mediated death of thyroid cancer cells. Endocrinology 148 (2007) 4352-4361
8. Epner D.E., Sawa A., and Isaacs J.T. Glyceraldehyde-3-phosphate dehydrogenase expression during apoptosis and proliferation of rat ventral prostate. Biol. Reprod. 61 (1999) 687-691
9. Gorell J.M., Johnson C.C., Rybicki B.A., Peterson E.L., and Richardson R.J. The risk of Parkinson's disease with exposure to pesticides, farming, well water, and rural living. Neurology 50 (1998) 1346-1350
10. Hara M.R., and Snyder S.H. Nitric oxide-GAPDH-Siah: a novel cell death cascade. Cell Mol. Neurobiol. 26 (2006) 527-538
11. Hara M.R., Agrawal N., Kim S.F., Cascio M.B., Fujimuro M., Ozeki Y., Takahashi M., Cheah J.H., Tankou S.K., Hester L.D., Ferris C.D., Hayward S.D., Snyder S.H., and Sawa A. S-nitrosylated GAPDH initiates apoptotic cell death by nuclear translocation following Siah1 binding. Nat. Cell Biol. 7 (2005) 665-674
12. Ishitani R., and Chuang D.M. Glyceraldehyde-3-phosphate dehydrogenase antisense oligodeoxynucleotides protect against cytosine arabinonucleoside-induced apoptosis in cultured cerebellar neurons. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 9937-9941
13. Ishitani R., Sunaga K., Hirano A., Saunders P., Katsube N., and Chuang D.M. Evidence that glyceraldehyde-3-phosphate dehydrogenase is involved in age-induced apoptosis in mature cerebellar neurons in culture. J. Neurochem. 66 (1996) 928-935
14. Ishitani R., Sunaga K., Tanaka M., Aishita H., and Chuang D.M. Overexpression of glyceraldehyde-3-phosphate dehydrogenase is involved in low K+-induced apoptosis but not necrosis of cultured cerebellar granule cells. Mol. Pharmacol. 51 (1997) 542-550
15. Kim C.I., Lee S.H., Seong G.J., Kim Y.H., and Lee M.Y. Nuclear translocation and overexpression of GAPDH by the hyper-pressure in retinal ganglion cell. Biochem. Biophys. Res. Commun. 341 (2006) 1237-1243
16. Kragten E., Lalande I., Zimmermann K., Roggo S., Schindler P., Muller D., van Oostrum J., Waldmeier P., and Furst P. Glyceraldehyde-3-phosphate dehydrogenase, the putative target of the antiapoptotic compounds CGP 3466 and R-(-)-deprenyl. J. Biol. Chem. 273 (1998) 5821-5828
17. Kusner L.L., Sarthy V.P., and Mohr S. Nuclear translocation of glyceraldehyde-3-phosphate dehydrogenase: a role in high glucose-induced apoptosis in retinal Muller cells. Invest. Ophthalmol. Vis. Sci. 45 (2004) 1553-1561
18. Mazzola J.L., and Sirover M.A. Reduction of glyceraldehyde-3-phosphate dehydrogenase activity in Alzheimer's disease and in Huntington's disease fibroblasts. J. Neurochem. 76 (2001) 442-449
19. Mazzola J.L., and Sirover M.A. Aging of human glyceraldehyde-3-phosphate dehydrogenase is dependent on its subcellular localization. Biochim. Biophys. Acta. 1722 (2005) 168-174
20. Menegon A., Board P.G., Blackburn A.C., Mellick G.D., and Le Couteur D.G. Parkinson's disease, pesticides, and glutathione transferase polymorphisms. Lancet 352 (1998) 1344-1346
21. Mohr S., Hallak H., de Boitte A., Lapetina E.G., and Brune B. Nitric oxide-induced S-glutathionylation and inactivation of glyceraldehyde-3-phosphate dehydrogenase. J. Biol. Chem. 274 (1999) 9427-9430
22. Nakajima H., Amano W., Fujita A., Fukuhara A., Azuma Y.T., Hata F., Inui T., and Takeuchi T. The active site cysteine of the proapoptotic protein glyceraldehyde-3-phosphate dehydrogenase is essential in oxidative stress-induced aggregation and cell death. J. Biol. Chem. 282 (2007) 26562-26574
23. Sen N., Hara M.R., Kornberg M.D., Cascio M.B., Bae B.I., Shahani N., Thomas B., Dawson T.M., Dawson V.L., Snyder S.H., and Sawa A. Nitric oxide-induced nuclear GAPDH activates p300/CBP and mediates apoptosis. Nat. Cell Biol. 10 (2008) 866-873
24. Sherer T.B., Kim J.H., Betarbet R., and Greenamyre J.T. Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation. Exp. Neurol. 179 (2003) 9-16
25. Sirover M.A. Role of the glycolytic protein, glyceraldehyde-3-phosphate dehydrogenase, in normal cell function and in cell pathology. J. Cell. Biochem. 66 (1997) 133-140
26. Souza J.M., and Radi R. Glyceraldehyde-3-phosphate dehydrogenase inactivation by peroxynitrite. Arch. Biochem. Biophys. 360 (1998) 187-194
27. Sunaga K., Takahashi H., Chuang D.M., and Ishitani R. Glyceraldehyde-3-phosphate dehydrogenase is over-expressed during apoptotic death of neuronal cultures and is recognized by a monoclonal antibody against amyloid plaques from Alzheimer's brain. Neurosci. Lett. 200 (1995) 133-136
28. Tarze A., Deniaud A., Le Bras M., Maillier E., Molle D., Larochette N., Zamzami N., Jan G., Kroemer G., and Brenner C. GAPDH, a novel regulator of the pro-apoptotic mitochondrial membrane permeabilization. Oncogene 26 (2007) 2606-2620
29. Tatton N.A. Increased caspase 3 and Bax immunoreactivity accompany nuclear GAPDH translocation and neuronal apoptosis in Parkinson's disease. Exp. Neurol. 166 (2000) 29-43
30. Tsuchiya K., Tajima H., Kuwae T., Takeshima T., Nakano T., Tanaka M., Sunaga K., Fukuhara Y., Nakashima K., Ohama E., Mochizuki H., Mizuno Y., Katsube N., and Ishitani R. Pro-apoptotic protein glyceraldehyde-3-phosphate dehydrogenase promotes the formation of Lewy body-like inclusions. Eur. J. Neurosci. 21 (2005) 317-326
31. Waldmeier P.C., Boulton A.A., Cools A.R., Kato A.C., and Tatton W.G. Neurorescuing effects of the GAPDH ligand CGP 3466B. J. Neural Transm. Suppl. (2000) 197-214
32. Wang C., Ko H.S., Thomas B., Tsang F., Chew K.C., Tay S.P., Ho M.W., Lim T.M., Soong T.W., Pletnikova O., Troncoso J., Dawson V.L., Dawson T.M., and Lim K.L. Stress-induced alterations in parkin solubility promote parkin aggregation and compromise parkin's protective function. Hum. Mol. Genet. 14 (2005) 3885-3897
33. Wang Q., Woltjer R.L., Cimino P.J., Pan C., Montine K.S., Zhang J., and Montine T.J. Proteomic analysis of neurofibrillary tangles in Alzheimer disease identifies GAPDH as a detergent-insoluble paired helical filament tau binding protein. FASEB J. 19 (2005) 869-871